Results 131 to 140 of about 30,662,577 (309)

Clinical Observation on Basal Ganglia Aphasia after Stroke Treated by Donepezil

open access: yes康复学报, 2015
Objective:To evaluate the curative effect of donepezil on basal ganglia aphasia after stroke.Methods:A total of 37 patients with basal ganglia aphasia after stroke were randomly assigned to donepezil group (n=19) and control group (n=18).
Xi CHENG   +5 more
doaj  

Insulin icodec: A once-weekly basal insulin on the horizon for diabetes management with implications for hospital care transitions

open access: yesHealth Sciences Review
Once-weekly basal insulin brings with it the promise of reduced treatment burden and the potential to usher in a new era of diabetes care. Practical guidance is needed for this paradigm shift in insulin administration in real-world hospital settings ...
Kai Xu   +3 more
doaj   +1 more source

Automated confidence ranked classification of randomized controlled trial articles: an aid to evidence-based medicine [PDF]

open access: bronze, 2015
Aaron Cohen   +6 more
openalex   +1 more source

rDNA insulin glargine U300 – a critical appraisal

open access: yesDiabetes, Metabolic Syndrome and Obesity, 2016
Fei Wang,1 Stefanie Zassman,1 Philip A Goldberg2 1Department of Pharmacy Practice, School of Pharmacy, University of Connecticut, Storrs, CT, USA; 2Department of Internal Medicine, Section of Endocrinology, Yale University School of Medicine, New Haven ...
Wang F, Zassman S, Goldberg PA
doaj  

Bridging Learning in Medicine and Citizenship During the COVID-19 Pandemic: A Telehealth-Based Strategy

open access: green, 2020
Thiago Cerqueira‐Silva   +15 more
openalex   +2 more sources

The Core Pattern Analysis on Chinese Herbal Medicine for Sjögren's syndrome: A Nationwide Population-Based Study [PDF]

open access: gold, 2015
Ching‐Mao Chang   +8 more
openalex   +1 more source

Are First-Year Emergency Medicine Residents Still Behind on Level 1 Care-Based Milestones? [PDF]

open access: diamond, 2023
Nathan D Stuempfig   +4 more
openalex   +1 more source

Home - About - Disclaimer - Privacy